OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00212555

Xiangtan Electrochemical Scientific Co Ltd

Commodity ChemicalsVerified

The company maintains a relatively strong liquidity position, with a current ratio of 2.1, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its liquidity risk is assessed as medium, and it has a negative net cash position after subtracting total debt, which could pose challenges in the event of a liquidity crunch. Profitability metrics show a return on equity (ROE) of 7.15% and a return on assets (ROA) of 4.49%. These figures are below the typical thresholds for high-performing chemical firms, suggesting that the company is generating returns, but not at a level that would be considered exceptional within the industry. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond China. This concentration increases exposure to local economic and regulatory risks, particularly in the chemical manufacturing sector. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. Historical revenue data shows a moderate level of consistency, but no clear upward or downward trend. Risk factors include a medium liquidity risk and a low dilution risk. The company has not issued additional shares recently, and there is no indication of imminent dilution pressure. However, the negative net cash position after debt suggests that the company may need to raise capital in the future, which could lead to share dilution. Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company continues to operate within its core electrochemical product lines, with no significant new product launches or market expansions disclosed in the latest available documents.

30-day price · 002125(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyXiangtan Electrochemical Scientific Co Ltd
Ticker002125.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Xiangtan Electrochemical Scientific Co Ltd is a Chinese chemical manufacturing company that produces and sells electrochemical products, primarily used in industrial and energy applications.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

The company maintains a relatively strong liquidity position, with a current ratio of 2.1, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its liquidity risk is assessed as medium, and it has a negative net cash position after subtracting total debt, which could pose challenges in the event of a liquidity crunch. Profitability metrics show a return on equity (ROE) of 7.15% and a return on assets (ROA) of 4.49%. These figures are below the typical thresholds for high-performing chemical firms, suggesting that the company is generating returns, but not at a level that would be considered exceptional within the industry. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond China. This concentration increases exposure to local economic and regulatory risks, particularly in the chemical manufacturing sector. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. Historical revenue data shows a moderate level of consistency, but no clear upward or downward trend. Risk factors include a medium liquidity risk and a low dilution risk. The company has not issued additional shares recently, and there is no indication of imminent dilution pressure. However, the negative net cash position after debt suggests that the company may need to raise capital in the future, which could lead to share dilution. Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company continues to operate within its core electrochemical product lines, with no significant new product launches or market expansions disclosed in the latest available documents.
Key takeaways
  • The company has a current ratio of 2.1, indicating adequate short-term liquidity but with a medium risk rating due to its negative net cash position after debt.
  • ROE and ROA are below industry benchmarks, suggesting that the company is not outperforming its peers in terms of profitability.
  • Revenue is concentrated in a single business segment and geographic region, increasing exposure to local economic and regulatory risks.
  • The company is expected to maintain a stable revenue trajectory with no significant growth or contraction in the near term.
  • Dilution risk is low, but the company may need to raise capital in the future, which could lead to share dilution.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUnknown error in universe processing
Revenue$1.92B
Gross profit$413.5M
Operating income$250.7M
Net income$225.4M
R&D
SG&A
D&A
SBC
Operating cash flow$200.0M
CapEx-$41.3M
Free cash flow$247.9M
Total assets$5.02B
Total liabilities$1.87B
Total equity$3.15B
Cash & equivalents
Long-term debt$1.34B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.15B
Net cash-$1.34B
Current ratio2.1
Debt/Equity0.4
ROA4.5%
ROE7.1%
Cash conversion89.0%
CapEx/Revenue-2.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002125Activity
Op margin13.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin11.7%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin21.5%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity42.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 23:53 UTCJob: 3696f463